Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab (BMS-936558, anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.